Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða

摘要

The invention provides a kind of pharmaceutical composition, it comprises aqueous carrier; 0.1mg/ml-20mg/ml the compositions of pharmaceutical salts of peptide, described peptide has following structural formula: NH ₂-Gly Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Glu Glu Trp IleGly-COOH; Beta-schardinger dextrin-with the replacement of the effective dose of dissolving peptide in aqueous carrier, wherein said compositions has the pH between 4-9, and the method and the method that relaxes the symptom of systemic lupus erythematosus (sle) (SLE) among the human experimenter that prepare aforementioned pharmaceutical compositions, it comprises to the human experimenter uses described pharmaceutical composition.